The airline will appoint six new directors to its board, avoiding a proxy fight with the activist investor Elliott Investment ...

Each year, the U.S. sees roughly 30,000 cases of invasive pneumococcal disease, which includes blood infections, brain and ...

All adults aged 50 and older should receive a vaccine against bacteria that can cause pneumonia and meningitis, federal ...

There's some rumbling going on within Pfizer's investment community, as an activist hedge fund says that the company's ...

An agency panel recommended lowering the age for routine vaccination from 65 to 50, boosting the revenue outlook for multiple ...

With an expanded recommendation from the Center for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization ...

“These promising data add to the evidence supporting GSK’s RSV vaccine and could help expand protection to more adults at ...

Among companies paying dividends above 4%, five stand out for their market strength and sustainable payouts. With yields ...

Abrysvo is the first and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 years.